Home
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- Modern Science Confirms Ancient Wisdom!
- Modern Science Confirms Ancient Wisdom!
- "Natural" or "Plant-Derived" Labeling Can Mislead
- CDN: Natural Health Products Report - Update
- NPI Editorial: Are we using Best Practices?
- AHPA Update: Kava Information from the AHPA Executive Committee
- European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing
- Statement on Kava in New Zealand
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- National Enzyme Company Announces TGA Recertification
National Enzyme Company has announced their TGA recertification after a recent audit performed by TGA representatives.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- China-Biotics, Inc. Reports FY10 Q1 Results
China-Biotics, Inc., has announced their FY10 Q1 results, reporting net sales increased 35.5% to $15.4 million from $11.4 million a year ago. The increase resulted from an increase in sales volume from new products, most of which were sold in the Company's Shining-branded retail outlets, significant growth in the bulk additive business and sales price increases on bulk additives products.
- GeoPharma Announces FY10 Q1 Results
GeoPharma, Inc., has announced their FY10 Q1 results, reporting revenues from continuing operations in the Manufacturing Segment decreased from approximately $6.2 million dollars to approximately $4.6 versus the first quarter of fiscal year 2009.
- GeoPharma Announces FY10 Q1 Results
GeoPharma, Inc., has announced their FY10 Q1 results, reporting revenues from continuing operations in the Manufacturing Segment decreased from approximately $6.2 million dollars to approximately $4.6 versus the first quarter of fiscal year 2009.
- GeoPharma Announces FY10 Q1 Results
GeoPharma, Inc., has announced their FY10 Q1 results, reporting revenues from continuing operations in the Manufacturing Segment decreased from approximately $6.2 million dollars to approximately $4.6 versus the first quarter of fiscal year 2009.
- Skinny Nutritional Corp. Reports FY09 Q2 Revenues
Skinny Nutritional Corp., has announced their revenues for FY09 Q2, reporting net revenues of $1,190,960 for the three months ending June 30, 2009. This represents an increase of $1,011,374 (563%) over revenues for the three months ending June 30, 2008.
- Skinny Nutritional Corp. Reports FY09 Q2 Revenues
Skinny Nutritional Corp., has announced their revenues for FY09 Q2, reporting net revenues of $1,190,960 for the three months ending June 30, 2009. This represents an increase of $1,011,374 (563%) over revenues for the three months ending June 30, 2008.
- Skinny Nutritional Corp. Reports FY09 Q2 Revenues
Skinny Nutritional Corp., has announced their revenues for FY09 Q2, reporting net revenues of $1,190,960 for the three months ending June 30, 2009. This represents an increase of $1,011,374 (563%) over revenues for the three months ending June 30, 2008.
- E.T. Horn Selected For Exclusive Omega Fields Distribution
The E.T. Horn Company has announced that it will distribute animal nutrition products and ingredients from Omega Fields throughout Arizona and California.
- E.T. Horn Selected For Exclusive Omega Fields Distribution
The E.T. Horn Company has announced that it will distribute animal nutrition products and ingredients from Omega Fields throughout Arizona and California.
- E.T. Horn Selected For Exclusive Omega Fields Distribution
The E.T. Horn Company has announced that it will distribute animal nutrition products and ingredients from Omega Fields throughout Arizona and California.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- Major investment for Danisco in the fast-growing cultures market
Danisco has announced investments totalling 60 million euros that will add more than 2,000 tonnes to its existing cultures production capacity over the next three years. These investments will meet growing global demand for frozen and freeze-dried Direct Vat Inoculants (DVI) and reinforce Danisco’s leading market position as a cultures supplier.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- BioGaia Issues Interim report
Biogaia reports net sales of SEK 112.4 million (72.4), an increase of SEK 40.0 million (55%) over prior year, with profit before tax of SEK 31.3 million (13.6), an increase of SEK 17.7 million.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- ChromaDex Reports Second Quarter 2009 Financial Results
ChromaDex Corporation has announced FY09 Q2 results, reporting a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended July 4, 2009, with cash, cash equivalents, and marketable securities totaling $606,575. The company recorded revenue of $1,342,716 as compared to $1,198,885 for the same period in 2008.
- Premium Ingredients International Establishes Distribution in Canada
Premium Ingredients International has established PII Food Ingredients to expand distribution into Canada. PII Food Ingredients will operate as a division of Bulk Pharmaceuticals Corporation, Scarborough, Ontario.
- Premium Ingredients International Establishes Distribution in Canada
Premium Ingredients International has established PII Food Ingredients to expand distribution into Canada. PII Food Ingredients will operate as a division of Bulk Pharmaceuticals Corporation, Scarborough, Ontario.
- Premium Ingredients International Establishes Distribution in Canada
Premium Ingredients International has established PII Food Ingredients to expand distribution into Canada. PII Food Ingredients will operate as a division of Bulk Pharmaceuticals Corporation, Scarborough, Ontario.
- Premium Ingredients International Establishes Distribution in Canada
Premium Ingredients International has established PII Food Ingredients to expand distribution into Canada. PII Food Ingredients will operate as a division of Bulk Pharmaceuticals Corporation, Scarborough, Ontario.
- Perrigo Reports Record FY09 Q4 and Full Year Results
Perrigo Company has announced their FY09 Q4 and full year results, reporting net sales from continuing operations for the fourth quarter of fiscal 2009 were $508 million, an increase of 7%. Reported income from continuing operations was $32 million, or $0.35 per share, relatively flat compared with $32 million, or $0.34 per share, a year ago. Excluding charges as outlined in Table II at the end of this release, fourth quarter fiscal 2009 adjusted income from continuing operations was $47 million, or $0.50 per share.
- Perrigo Reports Record FY09 Q4 and Full Year Results
Perrigo Company has announced their FY09 Q4 and full year results, reporting net sales from continuing operations for the fourth quarter of fiscal 2009 were $508 million, an increase of 7%. Reported income from continuing operations was $32 million, or $0.35 per share, relatively flat compared with $32 million, or $0.34 per share, a year ago. Excluding charges as outlined in Table II at the end of this release, fourth quarter fiscal 2009 adjusted income from continuing operations was $47 million, or $0.50 per share.
- Perrigo Reports Record FY09 Q4 and Full Year Results
Perrigo Company has announced their FY09 Q4 and full year results, reporting net sales from continuing operations for the fourth quarter of fiscal 2009 were $508 million, an increase of 7%. Reported income from continuing operations was $32 million, or $0.35 per share, relatively flat compared with $32 million, or $0.34 per share, a year ago. Excluding charges as outlined in Table II at the end of this release, fourth quarter fiscal 2009 adjusted income from continuing operations was $47 million, or $0.50 per share.
- InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
InterMed Discovery has announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
- InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
InterMed Discovery has announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
- InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
InterMed Discovery has announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
- InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
InterMed Discovery has announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
- InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
InterMed Discovery has announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
- InterMed Discovery Acquires Sustainable Source for Omega-3 Fatty Acid
InterMed Discovery has announced the acquisition of unique microbial Omega-3 fatty acid production strains and related know-how from the University of Saarland.
- LifeVantage Enters International Market
LifeVantage Corporation has announced that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
- LifeVantage Enters International Market
LifeVantage Corporation has announced that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
- LifeVantage Enters International Market
LifeVantage Corporation has announced that independent distributor applications and orders are being accepted in Mexico in anticipation of a launch late this summer.
- Former Country Life Vitamins Executive Seeks to Acquire Nutraceutical International Corp.
Ryan Drexler, a former senior executive and equity owner of market-leading Country Life Vitamins and holder of 341,000 shares, or 3.1% of the outstanding common stock of Nutraceutical International Corp., today announced his proposal to acquire all of the outstanding shares of Nutraceutical International Corp., in a negotiated all-cash transaction of $10.75 per share.
- Former Country Life Vitamins Executive Seeks to Acquire Nutraceutical International Corp.
Ryan Drexler, a former senior executive and equity owner of market-leading Country Life Vitamins and holder of 341,000 shares, or 3.1% of the outstanding common stock of Nutraceutical International Corp., today announced his proposal to acquire all of the outstanding shares of Nutraceutical International Corp., in a negotiated all-cash transaction of $10.75 per share.
- Former Country Life Vitamins Executive Seeks to Acquire Nutraceutical International Corp.
Ryan Drexler, a former senior executive and equity owner of market-leading Country Life Vitamins and holder of 341,000 shares, or 3.1% of the outstanding common stock of Nutraceutical International Corp., today announced his proposal to acquire all of the outstanding shares of Nutraceutical International Corp., in a negotiated all-cash transaction of $10.75 per share.
- Baywood International, Inc. Announces Shareholder Update and FY09 Q2 Results
Baywood International, Inc., has announced their FY09 Q2 results, reporting unaudited sales for the three and six months ended June 30, 2009 were $1,189,000 and $1,890,000, respectively, compared to zero for the same periods last year.
- Baywood International, Inc. Announces Shareholder Update and FY09 Q2 Results
Baywood International, Inc., has announced their FY09 Q2 results, reporting unaudited sales for the three and six months ended June 30, 2009 were $1,189,000 and $1,890,000, respectively, compared to zero for the same periods last year.
- Baywood International, Inc. Announces Shareholder Update and FY09 Q2 Results
Baywood International, Inc., has announced their FY09 Q2 results, reporting unaudited sales for the three and six months ended June 30, 2009 were $1,189,000 and $1,890,000, respectively, compared to zero for the same periods last year.
- NBTY Acquisition of Julian Graves Formally Approved by UK Competition Commission
NBTY, Inc., has announced that its acquisition of Julian Graves has been formally cleared in the United Kingdom by the UK Competition Commission.
- NBTY Acquisition of Julian Graves Formally Approved by UK Competition Commission
NBTY, Inc., has announced that its acquisition of Julian Graves has been formally cleared in the United Kingdom by the UK Competition Commission.
- NBTY Acquisition of Julian Graves Formally Approved by UK Competition Commission
NBTY, Inc., has announced that its acquisition of Julian Graves has been formally cleared in the United Kingdom by the UK Competition Commission.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Manitoba Harvest Welcomes New Marketing Manager to Team
Manitoba Harvest Hemp Foods & Oils has announced that Kelly Saunderson has taken over as the Marketing Manager.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
Martek Biosciences Corporation has announced that it has entered into a multi-year, sole-source supply agreement with Milk Powder Solutions, based in Australia.
- Jamba, Inc. Reports FY09 Q2 Results
Jamba, Inc., has announced their FY09 Q2 results, reporting total revenue for FY09 Q2 decreased 15.1% to $83.2 million from $98.0 million for FY08 Q2.
- Jamba, Inc. Reports FY09 Q2 Results
Jamba, Inc., has announced their FY09 Q2 results, reporting total revenue for FY09 Q2 decreased 15.1% to $83.2 million from $98.0 million for FY08 Q2.
- Jamba, Inc. Reports FY09 Q2 Results
Jamba, Inc., has announced their FY09 Q2 results, reporting total revenue for FY09 Q2 decreased 15.1% to $83.2 million from $98.0 million for FY08 Q2.
- JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC, announced that it will reject the non-binding proposal by Lonza Group AG to acquire all of the outstanding Restricted Voting Shares of Patheon Inc.
- JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC, announced that it will reject the non-binding proposal by Lonza Group AG to acquire all of the outstanding Restricted Voting Shares of Patheon Inc.
- JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC, announced that it will reject the non-binding proposal by Lonza Group AG to acquire all of the outstanding Restricted Voting Shares of Patheon Inc.
- JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC, announced that it will reject the non-binding proposal by Lonza Group AG to acquire all of the outstanding Restricted Voting Shares of Patheon Inc.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
innoVactiv joins forces with WEDAR Biotechnology Co. based in Taiwan to market its ingredient InSea2™ in Taiwan as well as in China. The exclusive agreement with WEDAR is for an initial five-year term.
InSea2™ is the only product on the market today that exhibits a dual mechanism of action against digestive enzymes involved in carbohydrate digestion and assimilation. It is an optimized blend of polyphenols derived from two species of brown seaweed. InSea2™ selectively blocks digestive enzymes and diminishes the hyper-glycemic peak following a high-glycemic index (GI) meal. Specifically, InSea2™ has demonstrated potent inhibiting effects against both α-glucosidase and α-amylase enzymes. By consuming InSea2™ before meals, the rate of carbohydrate absorption can be significantly slowed, eventually resulting in reduced conversion of glucose to stored body fat.
“We are very happy and proud to be represented by WEDAR which has the capacity and expertise to successfully promote innovative, science backed ingredients on the Chinese and Taiwanese markets” says Patrice Dionne, Chief Executive Officer of innoVactiv.
China and Taiwan represent together a population of over 1.3 billion people and WEDAR has a dedicated sales force network strategically positioned to penetrate each of the marketing channels of the dietary supplements industry in these two countries.
“We are proud to have the opportunity to work with a company like innoVactiv that have a true commitment in becoming experts in science-based ingredients. This great achievement offers great potential for both business partners” says Kevin Hu, President of WEDAR Biotechnology Co.
About innoVactiv
InnoVactiv’s mission is to develop and supply innovative ingredients whose efficacy and safety have been scientifically demonstrated. In addition to its two newest nutraceutical active ingredients, InSea2™ and PeptiBal™, innoVactiv has developed a line of 16 cosmeceutical ingredients and holds a strong development pipeline of additional ingredients that will offer solutions for maintaining optimal human health. For more information on innoVactiv, contact Patrice Dionne: pdionne@innovactiv.com or visit www.innovactiv.com
About WEDAR Biotechnology Co.
Wedar Biotechnology is an internationally operated nutraceutical ingredient supplier and product developer for the nutraceutical industry. WEDAR represent branded ingredients and supply to Asia industries. WEDAR’s main office is based in Taiwan, with branches in Shanghai and Los Angeles. For more information on WEDAR Biotechnology Co., contact Kevin Hu: kevin@wedar.com or visit www.wedar.com |